ГастроПортал Гастроэнтерологический портал России

Agents Actions Suppl

Immunomodulation of Crohn''s disease by interleukin-10.

Narula SK. Cutler D. Grint P.
Schering-Plough Research Institute, Kenilworth, NJ 07033, USA.
Interleukin-10 is an important cytokine that is involved in regulation of pro-inflammatory cytokines and T-cell responses. Interleukin-10 has been studied extensively in various preclinical and clinical models of inflammation. The most remarkable and consistently reproducible quality of IL-10 is its ability to downregulate macrophage functions. This includes inhibiting the production of pro-inflammatory cytokines such TNF-alpha, Interleukin-1, Interleukin-6 and antigen presentation by these professional antigen presenting cells. Additionally, Interleukin-10 also has effects on various other cell types of hematopoietic origin such as B-cells, neutrophils, and most importantly T-cells. Interleukin-10 has shown efficacy in several models of autoimmune disease. The present article deals with the effect of Interleukin-10 in animal models of inflammatory bowel disease and the results of phase I clinical trials in normal human volunteers and chronic active Crohn's disease patients.

Источник: https://gastroportal.ru/science-articles-of-world-periodical-eng/agents-actions-suppl.html
© ГастроПортал